1. Home
  2. PCRX vs HYMC Comparison

PCRX vs HYMC Comparison

Compare PCRX & HYMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

SELL

Current Price

$36.48

Market Cap

1.5B

Sector

Health Care

ML Signal

SELL

Logo Hycroft Mining Holding Corporation

HYMC

Hycroft Mining Holding Corporation

SELL

Current Price

$15.31

Market Cap

1.5B

ML Signal

SELL

Company Overview

Basic Information
Metric
PCRX
HYMC
Founded
2006
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2010
2018

Fundamental Metrics

Financial Performance
Metric
PCRX
HYMC
Price
$36.48
$15.31
Analyst Decision
Hold
Buy
Analyst Count
9
2
Target Price
★ $33.57
$24.50
AVG Volume (30 Days)
958.5K
★ 2.1M
Earning Date
11-09-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 107.44
64.26
EPS
★ 0.89
N/A
Revenue
★ $541,533,000.00
N/A
Revenue This Year
$3.84
N/A
Revenue Next Year
$4.73
N/A
P/E Ratio
$40.96
★ N/A
Revenue Growth
★ 26.04
N/A
52 Week Low
$18.80
$9.19
52 Week High
$36.67
$58.73

Technical Indicators

Market Signals
Indicator
PCRX
HYMC
Relative Strength Index (RSI) 82.40 39.62
Support Level $22.00 N/A
Resistance Level $36.67 $22.27
Average True Range (ATR) 0.04 1.44
MACD -0.37 -0.03
Stochastic Oscillator 90.00 0.84

Price Performance

Historical Comparison
PCRX
HYMC

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About HYMC Hycroft Mining Holding Corporation

Hycroft Mining Holding Corp is a United States-based gold and silver exploration-stage issuer. The company owns and is focused on developing its property, the Hycroft Mine, located northwest of Winnemucca, Nevada.

Share on Social Networks: